03 Profile
Vital Signsby Bridgehead
Hansard to 4 November 2026 · 31,174 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Rare diseases
Yuri Zhulev: no licensed photograph is held, so the sector leader plate is shown instead.
Sector leader
Yuri Zhulev
co-chair of the All-Russian Union of Patients
1
0
0
0
0
0
0
0
0
0
0
0
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
1
press citation on 1 topic since 15 Dec 2025 · last quoted 15 Dec 2025
02 Quoted on · 1 of 29 topics
Yuri Zhulev: key facts
- Kind of voice
- Sector leader
- Role
- co-chair of the All-Russian Union of Patients
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 15 Dec 2025
04 The signal · where Yuri Zhulev sits on rare diseases
Ranked 25= of 231 voices quoted in the press on rare diseases, level with 206 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1=Vinay PrasadAcademicProfessor of Epidemiology and Biostatistics and Medicine; hematologist-oncologist, University of California, San Francisco (UCSF)4
- 1=David WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
- 1=Tuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
- 25=Christelle Huguet, Ph.D.Sector leaderR&D head and Executive Vice President at Ipsen1
- 25=Evgeniya ShapiroSector leaderCEO of PSK Pharma1
- 25=Yuri ZhulevSector leaderco-chair of the All-Russian Union of Patients1
- 25=Channa DebruyneSector leaderglobal clinical development lead, late-stage and LCM oncology, at Servier1
- 25=Clara Cali MellaSector leaderdata strategy lead at Bayer1
Showing the leaders and the ranks around 25=, of 231 voices · See every voice on the topic →
05 On the record · press
What Yuri Zhulev has said
By outlet · linked articles
- theins.press1
Where Yuri Zhulev has been quoted
Verbatim
“Trust in domestic manufacturers needs to be built, but not at any cost. Patients are wary when they are told that from now on only one manufacturer will supply their medicine. Doctors and patients should have the widest possible choice of treatment options.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.